Novo Nordisk A/S (LON:0TDD)

Novo Nordisk Statistics

Total Valuation

Novo Nordisk has a market cap or net worth of GBP 126.93 billion. The enterprise value is 138.95 billion.

Market Cap	126.93B
Enterprise Value	138.95B

Important Dates

The next confirmed earnings date is Wednesday, May 6, 2026.

Earnings Date	May 6, 2026
Ex-Dividend Date	Aug 18, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.34%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	28.44%
Float	3.19B

Valuation Ratios

The trailing PE ratio is 10.61 and the forward PE ratio is 11.76.

PE Ratio	10.61
Forward PE	11.76
PS Ratio	3.52
PB Ratio	5.60
P/TBV Ratio	16.98
P/FCF Ratio	18.43
P/OCF Ratio	9.12
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.75, with an EV/FCF ratio of 20.18.

EV / Earnings	11.61
EV / Sales	3.89
EV / EBITDA	7.75
EV / EBIT	8.55
EV / FCF	20.18

Financial Position

The company has a current ratio of 0.80, with a Debt / Equity ratio of 0.67.

Current Ratio	0.80
Quick Ratio	0.54
Debt / Equity	0.67
Debt / EBITDA	0.85
Debt / FCF	2.22
Interest Coverage	33.42

Financial Efficiency

Return on equity (ROE) is 60.70% and return on invested capital (ROIC) is 41.13%.

Return on Equity (ROE)	60.70%
Return on Assets (ROA)	17.43%
Return on Invested Capital (ROIC)	41.13%
Return on Capital Employed (ROCE)	42.97%
Weighted Average Cost of Capital (WACC)	5.36%
Revenue Per Employee	522,069
Profits Per Employee	173,031
Employee Count	69,150
Asset Turnover	0.61
Inventory Turnover	1.20

Taxes

In the past 12 months, Novo Nordisk has paid 3.28 billion in taxes.

Income Tax	3.28B
Effective Tax Rate	21.53%

Stock Price Statistics

The stock price has decreased by -49.03% in the last 52 weeks. The beta is 0.27, so Novo Nordisk's price volatility has been lower than the market average.

Beta (5Y)	0.27
52-Week Price Change	-49.03%
50-Day Moving Average	49.94
200-Day Moving Average	55.71
Relative Strength Index (RSI)	31.52
Average Volume (20 Days)	328,333

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novo Nordisk had revenue of GBP 36.10 billion and earned 11.97 billion in profits. Earnings per share was 2.69.

Revenue	36.10B
Gross Profit	29.75B
Operating Income	16.43B
Pretax Income	15.25B
Net Income	11.97B
EBITDA	17.91B
EBIT	16.43B
Earnings Per Share (EPS)	2.69

Balance Sheet

The company has 3.15 billion in cash and 15.30 billion in debt, with a net cash position of -12.15 billion.

Cash & Cash Equivalents	3.15B
Total Debt	15.30B
Net Cash	-12.15B
Net Cash Per Share	n/a
Equity (Book Value)	22.67B
Book Value Per Share	5.10
Working Capital	-5.05B

Cash Flow

In the last 12 months, operating cash flow was 13.91 billion and capital expenditures -7.02 billion, giving a free cash flow of 6.89 billion.

Operating Cash Flow	13.91B
Capital Expenditures	-7.02B
Free Cash Flow	6.89B
FCF Per Share	n/a

Margins

Gross margin is 82.41%, with operating and profit margins of 45.50% and 33.14%.

Gross Margin	82.41%
Operating Margin	45.50%
Pretax Margin	42.24%
Profit Margin	33.14%
EBITDA Margin	49.60%
EBIT Margin	45.50%
FCF Margin	19.08%

Dividends & Yields

This stock pays an annual dividend of 0.94, which amounts to a dividend yield of 2.47%.

Dividend Per Share	0.94
Dividend Yield	2.47%
Dividend Growth (YoY)	16.22%
Years of Dividend Growth	9
Payout Ratio	50.53%
Buyback Yield	0.34%
Shareholder Yield	2.81%
Earnings Yield	9.43%
FCF Yield	5.43%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on September 20, 2023. It was a forward split with a ratio of 2.

Last Split Date	Sep 20, 2023
Split Type	Forward
Split Ratio	2

Scores

Novo Nordisk has an Altman Z-Score of 5.15 and a Piotroski F-Score of 5.

Altman Z-Score	5.15
Piotroski F-Score	5